2022年9月28日

2022年9月28日东部时间上午喂饲纽约——(业务线)——万花筒,开拓一个操作系统,加快研究团队表现,今天宣布完成6美元的种子资金,共同由蜂鸟公司和维度,从含咖啡因的资本,参与SV天使,Hawktail和个人投资者。的资金将用于投资于产品开发和团队扩张,专注于软件工程师。科学组织越来越多地采用跨学科团队,从临床医生科学家工程师的长椅上。然而,有一个惊人的缺乏结构和清晰今天这种合作,使它很难正确追踪科学决策。此外,不仅生成的数据量呈指数增加,但数据是经常换手。许多组织外包项目的各种组件,这意味着数据经常在个人之间共享,跨团队,与外部合作伙伴,没有统一的方式来理解什么是谁干的。万花筒是一个基于云计算的研究平台,作为“科学中心”,映射的位置数据,与它互动,以及为什么。通过使用万花筒跟踪实验之间的关系,公司可以做出更好的产品和管道的决定,速度更快。平台不断研发团队同步通过集中项目的鸟瞰图和数据生成,并通过智能集成与其他软件自动化的结果。这使科学家能够读取和写入其他工具的技术堆栈,以直观的方式,增强协作在每个阶段的研究过程。 Researchers can now plan and track scientific work across both wet lab and computational teams, enabling more closed-loop systems to accelerate R&D. “The way people work in research is changing. Kaleidoscope bridges the gap between teams, on a platform that integrates with other software tools. The funding will enable us to deliver the best product and user experience to make research more collaborative, reproducible, and scalable,” said Bogdan Knezevic, Ph.D., CEO & Co-Founder, Kaleidoscope. “I’m thrilled to lead a team with co-founders Ahmed Elnaiem and David Yen to bring together diverse backgrounds across biology, engineering, and product design to build this foundational platform for the life sciences industry. We are building version control for science, to power tomorrow’s cures and scientific advances.” “The decentralization of data and work, and rise of computation has created a void where life science companies have resorted to spending hundreds of millions of dollars to build subpar internal tools that are not sustainable or scalable,” said Brandon White, Head of Product at Spring Discovery. “Data capture and meeting notes that sync with other applications have changed the way we work, but in life sciences there is a huge unmet need for more accessible cloud-based tools, so scientists can save time and make critical decisions faster to accelerate research. Kaleidoscope is a much-needed solution to this problem.” “Maintaining a single source of truth is critical in connecting and automating pipelines and workflows. Kaleidoscope is the connective tissue across wet lab and dry lab, integrating with the main tools of each arm to provide a holistic view of ongoing work,” said Pablo Lubroth, investor in Hummingbird Ventures. “There is an enormous amount of inefficiency and loss of productivity in manual data capture, disparate systems, and outdated tools. We’re extremely proud to support Kaleidoscope's next phase of growth to bring this much-needed solution to research teams.” “We launched Dimension as a dedicated firm at the convergence of tech and the life sciences. Industry is going through a drastic transformation. Discovery and clinical translation are no longer driven from siloed one-off experimentation but rather are compounding from accelerating gains in scale of data, reproducibility, and fidelity of experiment,” said Adam Goulburn, Founding Partner at Dimension. “The outcome here is an urgent and inevitable prioritization of large-scale cross-disciplinary research coordination, where data is no longer an afterthought. Kaleidoscope is addressing this need and building the operating system for modern scientific research. We are so thrilled to partner with the team here and are already seeing tremendous early engagement from the industry on this product.” About Kaleidoscope Kaleidoscope is a collaborative, cloud-based research platform designed for planning and tracking scientific work across wet lab and computational teams. By integrating with the modern research stack, we are changing the way research is conducted, with efficiency and transparency. Kaleidoscope is based in New York, NY. For more information, visit www.kaleidoscope.bio . Contacts